Home › Opioid Overdose › NCT07350148
Opioid Adherence and Support Through Innovative Texting Strategies
Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * 18 years of age or older * Have a cellphone that can receive text messages * Have internet access to complete study surveys * Willing to comply with all study procedures and be available for the duration of the study * Within 6 months of starting or resuming to take daily methadone or buprenorphine (or suboxone/subutex) * Able to understand study requirements and provide informed consent Exclusion Criteria: * None
About the study
The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of treatment. The main questions it aims to answer are:
1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. What impact does daily mindfulness text message quantity have on craving, pain, forgetfulness, and withdrawal symptoms?
Participants will:
1. Receive daily medication reminder text messages for at least 24 weeks (i.e., 6 months) 2. Receive up to 6 mindfulness messages per day for 4 weeks (i.e., 1 month) 3. Answer daily questions twice a day during the 4 weeks of mindfulness messages 4. Answer questions about the study when enrolling, at the end of the 4 weeks of mindfulness messages, and at 4 and 16 weeks after the end of the mindfulness messages
What is being tested
- Mindfulness text messages (behavioral)
Sponsor: University of New Mexico · Participants: 60 · Started: Oct 13, 2025
Contact the study team
- Frank Schwebel, PhD · Phone: 505-456-3014
Official record on ClinicalTrials.gov — NCT07350148
Locations in the U.S.
| New Mexico | University of New Mexico, Albuquerque |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.